Prognosis of rash and chilblain-like lesions among outpatients with COVID-19: a large cohort study

Hélène Mascitti; Patrick Jourdain; Alexandre Bleibtreu; Luc Jaulmes; Agnès Dechartres; François-Xavier Lescure; Youri Yordanov; Aurélien Dinh

doi:10.1007/s10096-021-04305-3

Prognosis of rash and chilblain-like lesions among outpatients with COVID-19: a large cohort study

Hélène Mascitti, Patrick Jourdain, Alexandre Bleibtreu, Luc Jaulmes, Agnès Dechartres, François-Xavier Lescure, Youri Yordanov, Aurélien Dinh

Research output: Contribution to journal › Article › peer-review

Abstract / Description of output

In a large regional observational cohort study of adult (≥ 18 years), outpatients with COVID-19, prevalence, characteristics, and outcome of patients with rash and/or chilblain-like lesions (CLL), compared with population without cutaneous features, were studied. In total, 28,957 outpatients were included; the prevalence of rash and CCL were 9.5% and 3.7%, respectively. Presence of rash was significantly associated with presence of asthenia, shivers or myalgia, respiratory and gastro-intestinal symptoms, and anosmia/ageusia. The presence of CCL was associated with chest pain, chest oppression, nausea/vomiting, and anosmia/ageusia. Patients with CCL were significantly less prone to an unfavourable outcome (hospitalization or death).

Original language	English
Pages (from-to)	2243-2248
Number of pages	6
Journal	European Journal of Clinical Microbiology and Infectious Diseases
Volume	40
Issue number	10
Early online date	13 Jul 2021
DOIs	https://doi.org/10.1007/s10096-021-04305-3
Publication status	Published - 1 Oct 2021

Keywords / Materials (for Non-textual outputs)

Rash
Chilblain-like lesion
COVID19
Risk Factors
Hospitalization

Access to Document

10.1007/s10096-021-04305-3Licence: All Rights Reserved

https://link.springer.com/article/10.1007/s10096-021-04305-3Licence: All Rights Reserved

Cite this

@article{78b22df3a7c74f3893f4fde84431075d,

title = "Prognosis of rash and chilblain-like lesions among outpatients with COVID-19: a large cohort study",

abstract = "In a large regional observational cohort study of adult (≥ 18 years), outpatients with COVID-19, prevalence, characteristics, and outcome of patients with rash and/or chilblain-like lesions (CLL), compared with population without cutaneous features, were studied. In total, 28,957 outpatients were included; the prevalence of rash and CCL were 9.5% and 3.7%, respectively. Presence of rash was significantly associated with presence of asthenia, shivers or myalgia, respiratory and gastro-intestinal symptoms, and anosmia/ageusia. The presence of CCL was associated with chest pain, chest oppression, nausea/vomiting, and anosmia/ageusia. Patients with CCL were significantly less prone to an unfavourable outcome (hospitalization or death).",

keywords = "Rash, Chilblain-like lesion, COVID19, Risk Factors, Hospitalization",

author = "H{\'e}l{\`e}ne Mascitti and Patrick Jourdain and Alexandre Bleibtreu and Luc Jaulmes and Agn{\`e}s Dechartres and Fran{\c c}ois-Xavier Lescure and Youri Yordanov and Aur{\'e}lien Dinh",

year = "2021",

month = oct,

day = "1",

doi = "10.1007/s10096-021-04305-3",

language = "English",

volume = "40",

pages = "2243--2248",

journal = "European Journal of Clinical Microbiology and Infectious Diseases",

issn = "1435-4373",

publisher = "Springer",

number = "10",

}

TY - JOUR

T1 - Prognosis of rash and chilblain-like lesions among outpatients with COVID-19: a large cohort study

AU - Mascitti, Hélène

AU - Jourdain, Patrick

AU - Bleibtreu, Alexandre

AU - Jaulmes, Luc

AU - Dechartres, Agnès

AU - Lescure, François-Xavier

AU - Yordanov, Youri

AU - Dinh, Aurélien

PY - 2021/10/1

Y1 - 2021/10/1

N2 - In a large regional observational cohort study of adult (≥ 18 years), outpatients with COVID-19, prevalence, characteristics, and outcome of patients with rash and/or chilblain-like lesions (CLL), compared with population without cutaneous features, were studied. In total, 28,957 outpatients were included; the prevalence of rash and CCL were 9.5% and 3.7%, respectively. Presence of rash was significantly associated with presence of asthenia, shivers or myalgia, respiratory and gastro-intestinal symptoms, and anosmia/ageusia. The presence of CCL was associated with chest pain, chest oppression, nausea/vomiting, and anosmia/ageusia. Patients with CCL were significantly less prone to an unfavourable outcome (hospitalization or death).

AB - In a large regional observational cohort study of adult (≥ 18 years), outpatients with COVID-19, prevalence, characteristics, and outcome of patients with rash and/or chilblain-like lesions (CLL), compared with population without cutaneous features, were studied. In total, 28,957 outpatients were included; the prevalence of rash and CCL were 9.5% and 3.7%, respectively. Presence of rash was significantly associated with presence of asthenia, shivers or myalgia, respiratory and gastro-intestinal symptoms, and anosmia/ageusia. The presence of CCL was associated with chest pain, chest oppression, nausea/vomiting, and anosmia/ageusia. Patients with CCL were significantly less prone to an unfavourable outcome (hospitalization or death).

KW - Rash

KW - Chilblain-like lesion

KW - COVID19

KW - Risk Factors

KW - Hospitalization

U2 - 10.1007/s10096-021-04305-3

DO - 10.1007/s10096-021-04305-3

M3 - Article

SN - 1435-4373

VL - 40

SP - 2243

EP - 2248

JO - European Journal of Clinical Microbiology and Infectious Diseases

JF - European Journal of Clinical Microbiology and Infectious Diseases

IS - 10

ER -

Prognosis of rash and chilblain-like lesions among outpatients with COVID-19: a large cohort study

Abstract / Description of output

Keywords / Materials (for Non-textual outputs)

Access to Document

Fingerprint

Cite this